A Pilot study, for mandatory Venous Thromboembolism (VTE) Risk Assessment and Prophylaxis Implementation for cost effectively improving VTE outcomes in hospitalized medical patients
Not Applicable
Completed
- Conditions
- Venous thromboembolism in hospitalised medical patientsPublic Health - Health service researchCardiovascular - Diseases of the vasculature and circulation including the lymphatic system
- Registration Number
- ACTRN12610001001088
- Lead Sponsor
- Clinical Trials Unit, St George Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 360
Inclusion Criteria
Hospital medical inpatient admissions
Exclusion Criteria
Patients admitted to psychatric, surgical and Paediatic wards,
Patients discharged on the day of admission.
Patients admitted for Deep Vein Thrombosis or Pulmonary Embolism treatment.
Patient or next of Kin refuses consent.
Patients currently on therapeutic anticoagulants. Warfarin Intravenous Heparin, fonadaprinux, rivaroxaban,darbigatran, and Aspirin 360mg/day or higher
Patients in palliative care, intensive care units and high dependancy units
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method